The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model

By Tennant Raymond W.   Stasiewicz Stanley   Eastin William C.   Mennear John H.   Spalding Judson W.  

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 51-59

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Tumor Spectrum in the p53 Heterozygous Zeta Globin-Promoted Tg.AC (v-Ha-ras) Bitransgenic Mouse Model

By Martin Keith   Jokinen Michael   Honeycutt Hayden   Quinn Anita   Kari Frank   Barrett J.   French John  

Toxicologic Pathology, Vol. 32, Iss. 4, 2004-07 ,pp. : 418-425

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Dermal Carcinogenicity in Transgenic Mice: Effect of Vehicle on Responsiveness of Hemizygous Tg.AC Mice to Phorbol 12-Myristate 13-Acetate (TPA)

By Stoll Raymond E.   Furst Sylvia M.   Stoltz James H.   Lilly Patrick D.   Mennear John H.  

Toxicologic Pathology, Vol. 29, Iss. 5, 2001-09 ,pp. : 535-540

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Effect of Oral Gavage Dosing Regimens in Female Tg rasH2 Transgenic Mice

By Morton Daniel   Sellers Rani   Furst Sylvia   Hawley Kristen   May Jeffrey  

Toxicologic Pathology, Vol. 32, Iss. 4, 2004-07 ,pp. : 413-417

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Skeletal Myopathy in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene

By Tsuchiya Takayuki   Kobayashi Kiyoshi   Sakairi Tetsuya   Goto Kazuhiro   Okada Miyoko   Sano Fumiko   Sugimoto Jiro   Morohashi Tetsuo   Usui Toshimi   Mutai Mamoru  

Toxicologic Pathology, Vol. 30, Iss. 4, 2002-07 ,pp. : 501-506

Ashgate Publishing Ltd

Access to resources Recommend Favorite